Richard C. Breeden - 16 May 2023 Form 4 Insider Report for STERIS plc (STE)

Role: Director
Signature: /s/ Ronald E. Snyder, Authorized Representative under Power of Attorney
Issuer symbol: STE
Transactions as of: 16 May 2023
Transactions value $: -$2,530,439
Form type: 4
Filing time: 18 May 2023, 16:35:18 UTC
Previous filing: 16 May 2023
Next filing: 07 Aug 2023
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	STE	Ordinary Shares	Sale	-$2.53M	-12.1K	-30.25%	$208.61	28K	16 May 2023	Direct	F1
holding	STE	Ordinary Shares						27.2K	16 May 2023	See Footnote Below	F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Price reflects a weighted average sale price for multiple transactions ranging from $208.50 to $209.33 per share, inclusive. The Reporting Person undertakes to provide, upon request by the SEC Staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each separate price.
F2	Pursuant to Rule 16a-1(a)(2)(ii)(B) of the Securities Exchange Act of 1934, as amended, Mr. Breeden in his capacity as managing member, as well as chairman and chief executive officer of Breeden Capital Management LLC and as the managing member of Breeden Capital Partners LLC, may be deemed to be the indirect beneficial owner of the ordinary shares owned by the Fund and its General Partner, and may be deemed to have beneficial ownership of all such shares. Mr. Breeden disclaims beneficial ownership over 1,359 of these shares held by Breeden Partnership LLP.

Content

Price reflects a weighted average sale price for multiple transactions ranging from $208.50 to $209.33 per share, inclusive. The Reporting Person undertakes to provide, upon request by the SEC Staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each separate price.

Pursuant to Rule 16a-1(a)(2)(ii)(B) of the Securities Exchange Act of 1934, as amended, Mr. Breeden in his capacity as managing member, as well as chairman and chief executive officer of Breeden Capital Management LLC and as the managing member of Breeden Capital Partners LLC, may be deemed to be the indirect beneficial owner of the ordinary shares owned by the Fund and its General Partner, and may be deemed to have beneficial ownership of all such shares. Mr. Breeden disclaims beneficial ownership over 1,359 of these shares held by Breeden Partnership LLP.